Variant report
Variant | nsv900339 |
---|---|
Chromosome Location | chr13:64714831-64795587 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:64792758..64793744-chr7:131539225..131540176,2 | MCF-7 | breast: | |
2 | chr13:64733418..64735180-chr13:64740431..64742208,2 | MCF-7 | breast: | |
3 | chr13:64753621..64755784-chr13:64760416..64762529,2 | K562 | blood: | |
4 | chr13:64475617..64476410-chr13:64728809..64729366,2 | MCF-7 | breast: | |
5 | chr13:64753621..64755784-chr13:64760416..64762529,2 | K562 | blood: | |
6 | chr13:64733418..64735180-chr13:64740431..64742208,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571790636 | chr13:64730212-64730213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs9317391 | chr13:64730216-64730217 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs563858190 | chr13:64730265-64730266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs531158825 | chr13:64730334-64730335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs201922698 | chr13:64730335-64730336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs375999294 | chr13:64730371-64730372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540943403 | chr13:64730381-64730382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559559160 | chr13:64730400-64730401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs61959270 | chr13:64730421-64730422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs572586942 | chr13:64730455-64730456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563030428 | chr13:64730500-64730501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs9598732 | chr13:64730583-64730584 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs189440677 | chr13:64730609-64730610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs567038064 | chr13:64730614-64730615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534416168 | chr13:64730664-64730665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs76892481 | chr13:64730667-64730668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570934045 | chr13:64730674-64730675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537844946 | chr13:64730704-64730705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs377062913 | chr13:64730716-64730717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529523586 | chr13:64730730-64730731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs376159960 | chr13:64730818-64730819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs576977416 | chr13:64730836-64730837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568244826 | chr13:64730869-64730870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs569847120 | chr13:64730891-64730892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553665156 | chr13:64730898-64730899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs9598733 | chr13:64730937-64730938 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs181557193 | chr13:64730972-64730973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs185696471 | chr13:64730975-64730976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs576127528 | chr13:64730977-64730978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs543047323 | chr13:64730983-64730984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550293198 | chr13:64730998-64730999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs144696428 | chr13:64731035-64731036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs78354434 | chr13:64731038-64731039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs561750984 | chr13:64731067-64731068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs568569273 | chr13:64731080-64731081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530312464 | chr13:64731105-64731106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530058459 | chr13:64731126-64731127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560770524 | chr13:64731164-64731165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs140567927 | chr13:64731179-64731180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs144410245 | chr13:64731180-64731181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs201172280 | chr13:64731215-64731216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs73197111 | chr13:64731219-64731220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189471775 | chr13:64731271-64731272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs151187461 | chr13:64731275-64731276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs71442621 | chr13:64731342-64731343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs150332113 | chr13:64731360-64731361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs527755583 | chr13:64731387-64731388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs199990332 | chr13:64731408-64731409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs553601351 | chr13:64731414-64731415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565643450 | chr13:64731474-64731475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:64730200-64730800 | Enhancers | HUVEC | blood vessel |
2 | chr13:64730800-64732600 | Weak transcription | HUVEC | blood vessel |
3 | chr13:64732400-64732600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr13:64732600-64733000 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr13:64732600-64734000 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr13:64732600-64734000 | Enhancers | HUVEC | blood vessel |
7 | chr13:64733000-64733600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr13:64738600-64738800 | Enhancers | Gastric | stomach |
9 | chr13:64743800-64745800 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr13:64745800-64747000 | Weak transcription | Muscle Satellite Cultured Cells | -- |
11 | chr13:64747000-64747400 | Enhancers | Muscle Satellite Cultured Cells | -- |
12 | chr13:64760600-64761200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr13:64764600-64765000 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
14 | chr13:64770800-64771000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr13:64771200-64779600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr13:64780600-64781000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr13:64780600-64781200 | ZNF genes & repeats | Esophagus | oesophagus |
18 | chr13:64780600-64781400 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
19 | chr13:64780800-64781400 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |